Common biomarkers like amyloid-β (Aβ), total tau (T-tau), and phosphorylated tau (P-tau) reflect the pathological condition of AD and contribute to the diagnosis in the preclinical stage (Blennow and Zetterberg, 2018). The gene discussed is MAPT; the disease is Alzheimer disease.